Imperva (NASDAQ:IMPV) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday. The brokerage currently has a $62.00 price objective on the software maker’s stock. Zacks Investment Research‘s price target indicates a potential upside of 11.99% from the stock’s current price.

According to Zacks, “Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company’s SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. “

Several other research firms have also commented on IMPV. JPMorgan Chase & Co. boosted their price objective on Imperva from $45.00 to $48.00 and gave the stock an “underweight” rating in a research note on Friday, July 27th. Monness Crespi & Hardt lowered Imperva from a “buy” rating to a “neutral” rating and set a $52.00 price objective for the company. in a research note on Friday, July 27th. DA Davidson lowered Imperva from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $56.00 to $46.00 in a research note on Friday, July 27th. Oppenheimer lowered Imperva from an “outperform” rating to a “market perform” rating and set a $70.00 price objective for the company. in a research note on Friday, July 27th. Finally, UBS Group lowered Imperva from an “outperform” rating to a “market perform” rating in a research note on Friday, July 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Imperva currently has an average rating of “Hold” and a consensus price target of $56.37.

Shares of Imperva stock traded up $0.07 on Friday, hitting $55.36. The company’s stock had a trading volume of 3,138,200 shares, compared to its average volume of 435,267. Imperva has a 1 year low of $37.17 and a 1 year high of $57.65. The firm has a market cap of $1.61 billion, a PE ratio of -197.71 and a beta of 1.72.

Imperva (NASDAQ:IMPV) last posted its quarterly earnings data on Thursday, July 26th. The software maker reported ($0.26) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.33) by $0.07. Imperva had a negative return on equity of 6.92% and a negative net margin of 8.59%. The company had revenue of $84.80 million during the quarter, compared to analyst estimates of $87.22 million. During the same period in the previous year, the business earned $0.24 EPS. Imperva’s quarterly revenue was up 13.9% on a year-over-year basis. Sell-side analysts anticipate that Imperva will post -1.15 earnings per share for the current fiscal year.

Several institutional investors have recently modified their holdings of the company. BlackRock Inc. boosted its holdings in shares of Imperva by 4.0% during the 2nd quarter. BlackRock Inc. now owns 2,362,641 shares of the software maker’s stock worth $113,997,000 after purchasing an additional 91,444 shares during the last quarter. RGM Capital LLC boosted its holdings in shares of Imperva by 0.8% during the 2nd quarter. RGM Capital LLC now owns 1,777,212 shares of the software maker’s stock worth $85,750,000 after purchasing an additional 14,045 shares during the last quarter. Rothschild Asset Management Inc. boosted its holdings in shares of Imperva by 18.4% during the 2nd quarter. Rothschild Asset Management Inc. now owns 594,441 shares of the software maker’s stock worth $28,682,000 after purchasing an additional 92,349 shares during the last quarter. Bank of America Corp DE boosted its holdings in shares of Imperva by 1.2% during the 2nd quarter. Bank of America Corp DE now owns 528,022 shares of the software maker’s stock worth $25,478,000 after purchasing an additional 6,443 shares during the last quarter. Finally, Legal & General Group Plc boosted its holdings in shares of Imperva by 27.9% during the 2nd quarter. Legal & General Group Plc now owns 519,725 shares of the software maker’s stock worth $25,077,000 after purchasing an additional 113,280 shares during the last quarter. Institutional investors and hedge funds own 99.99% of the company’s stock.

Imperva Company Profile

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Featured Story: How Do I Invest in Dividend Stocks

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.